 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

---
- 'Intellipharmaceutics International (IPCIF): Q3 GAAP EPS of -C$0.04.As of August
  31, 2021, our cash balance was C$1.11MPress Release'


Intellipharmaceutics International reports Q3 results

---
- Intellipharmaceutics International Inc. (OTCMKTS:IPCIF) (TSX:I) was the recipient
  of a significant growth in short interest during the month of May. As of May 28th,
  there was short interest totalling 1,900 shares, a growth of 111.1% from the May
  13th total of 900 shares. Based on an average daily ...


Intellipharmaceutics International Inc. (OTCMKTS:IPCIF) Short Interest Up 111.1% in May

---
- Intellipharmaceutics International Inc. (OTCMKTS:IPCIF) (TSX:I) was the target of
  a large decline in short interest in May. As of May 14th, there was short interest
  totalling 900 shares, a decline of 59.1% from the April 29th total of 2,200 shares.
  Based on an average daily trading volume, of 23,500...


Intellipharmaceutics International Inc. (OTCMKTS:IPCIF) Short Interest Update

---
- Intellipharmaceutics International Inc. (OTCMKTS:IPCIF) (TSX:I) was the target of
  a large increase in short interest in April. As of April 15th, there was short interest
  totalling 12,000 shares, an increase of 60.0% from the March 31st total of 7,500
  shares. Based on an average trading volume of 34,...


Short Interest in Intellipharmaceutics International Inc. (OTCMKTS:IPCIF) Rises By 60.0%

---
- Intellipharmaceutics International Inc. (OTCMKTS:IPCIF) (TSX:I) crossed above its
  two hundred day moving average during trading on Tuesday . The stock has a two hundred
  day moving average of $0.18 and traded as high as $0.24. Intellipharmaceutics International
  shares last traded at $0.22, with a ...


Intellipharmaceutics International (OTCMKTS:IPCIF) Stock Passes Above 200 Day Moving Average of $0.18

---
- 'Intellipharmaceutics International (OTC:IPCIF): Q1 GAAP EPS of -$0.04.Cash balance
  of $202.67K.Press Release'


Intellipharmaceutics International reports Q1 results

---
- Intellipharmaceutics International Inc. (OTCMKTS:IPCIF) (TSX:I) crossed above its
  200-day moving average during trading on Monday . The stock has a 200-day moving
  average of $0.18 and traded as high as $0.21. Intellipharmaceutics International
  shares last traded at $0.21, with a volume of 27,354 ...


Intellipharmaceutics International (OTCMKTS:IPCIF) Share Price Passes Above Two Hundred Day Moving Average of $0.18

---
- Intellipharmaceutics International Inc. (OTCMKTS:IPCIF) (TSX:I)s stock price passed
  above its 200-day moving average during trading on Monday . The stock has a 200-day
  moving average of $0.18 and traded as high as $0.21. Intellipharmaceutics International
  shares last traded at $0.21, with a volume ...


Intellipharmaceutics International (OTCMKTS:IPCIF) Shares Cross Above 200 Day Moving Average of $0.18

---
- Intellipharmaceutics International Inc. (OTCMKTS:IPCIF) (TSX:I) was the target of
  a large decrease in short interest during the month of February. As of February
  26th, there was short interest totalling 13,400 shares, a decrease of 22.5% from
  the February 11th total of 17,300 shares. Based on an ...


---
- Intellipharmaceutics International Inc. (OTCMKTS:IPCIF) (TSX:I) passed above its
  200-day moving average during trading on Tuesday . The stock has a 200-day moving
  average of $0.17 and traded as high as $0.21. Intellipharmaceutics International
  shares last traded at $0.20, with a volume of 27,497 ...


Intellipharmaceutics International (OTCMKTS:IPCIF) Share Price Passes Above 200-Day Moving Average of $0.17

Intellipharmaceutics International, Inc. is a pharmaceutical company, which engages in the research, development, and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a controlled-release drug delivery platform that can be applied to the development of pharmaceuticals in the areas of neurology, cardiovascular, gastrointestinal tract, diabetes, and pain. The company was founded by Isa Odidi and Amina Odidi on October 22, 2009 and is headquartered in Toronto, Canada.

Watchers	5,831
52-Wk Low	$0.0012
52-Wk High	$0.1068

Market Cap	$2.7M
Volume (M)	10.00
52-Wk High	$0.1068
52-Wk Low	$0.0012

Current Price	$0.0815
Prev Close	$0.0685
Open	$0.0815
Dividend Yield	0.00%
50-Day Moving Average	$0.0787
Beta	1.07
Avg. Volume	6,650.09
PE Ratio	-1.71

52-Week High	$0.1068
52-Week Low	$0.0012
Market Capitalization	$2.7M
EPS	-$0.0478
Price to Book	-0.25
Revenue Per Employee	N/A
Enterprise Value/EBITDA	-5.12

IPCI IntelliPharmaCeutics International Inc.

About

Feed

News

Fundamentals